OSTEOPOROSIS IN EUROPE by Cooper, C

Definition and prevalence of osteoarthritis in Europe by Cooper, C, Walker-Bone, K, Dennison, E, Javaid, M, Coggon, D, Arden, N

Risk factors for osteoporosis in Europe. by Lau, E, Cooper, C

Challenges for the development of bone-forming agents in Europe by Kanis, J, Rizzoli, R, Cooper, C, Reginster, J

Challenges for the development of bone-forming agents in Europe. by Kanis, J, Rizzoli, R, Cooper, C, Reginster, J

Epidemiology of Paget's disease in Europe: the prevalence is decreasing. by Poór, G, Donáth, J, Fornet, B, Cooper, C

“…INTRODUCTION: To estimate secular changes in the age-and sex-specific prevalence of Paget's disease of bone in Europe, we conducted a second radiographic survey using identical sampling and methods in six European towns where a baseline study was performed in 1978-1979. …”

Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). by Felsenberg, D, Silman, A, Lunt, M, Armbrecht, G, Ismail, A, Finn, J, Cockerill, W, Banzer, D, Benevolenskaya, L, Bhalla, A, Bruges Armas, J, Cannata, J, Cooper, C, Dequeker, J, Eastell, R, Felsch, B, Gowin, W, Havelka, S, Hoszowski, K, Jajic, I, Janott, J, Johnell, O, Kanis, J, Kragl, G, Lopes Vaz, A

“…There was some evidence of geographic variation in fracture occurrence; rates were higher in Sweden than elsewhere in Europe. This is the first large population-based study to ascertain the incidence of vertebral fracture in men and women over 50 years of age across Europe. …”

Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). by Ismail, A, Pye, SR, Cockerill, W, Lunt, M, Silman, A, Reeve, J, Banzer, D, Benevolenskaya, L, Bhalla, A, Bruges Armas, J, Cannata, J, Cooper, C, Delmas, P, Dequeker, J, Dilsen, G, Falch, J, Felsch, B, Felsenberg, D, Finn, J, Gennari, C, Hoszowski, K, Jajic, I, Janott, J, Johnell, O, Kanis, J

“…The aim of this population-based prospective study was to determine the incidence of limb fracture by site and gender in different regions of Europe. Men and women aged 50-79 years were recruited from population registers in 31 European centers. …”

Trauma Type of Non-hip, Non-vertebral Fractures in Postmenopausal Women Being Treated for Osteoporosis in Europe. by Roux, C, Cooper, C, Ortolani, S, Diez-Perez, A, Horne, R, Franchimont, N, Easton, V, Freemantle, N

PREVALENT FRACTURES IN POSTMENOPAUSAL WOMEN BEING TREATED FOR OSTEOPOROSIS IN EUROPE: RELATIONSHIP BETWEEN TRAUMA TYPE, TIME RELATIVE TO MENOPAUSE, AND FRACTURE LOCATION by Roux, C, Cooper, C, Ortolani, S, Diez-Perez, A, Horne, R, Franchimont, N, Shepherd, S, Moeller, G, Freemantle, N

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a mutli-national study including data from Denmark, Spain, and the UK by Khalid, S, Ernst, M, Rubin, K, Martinez-Laguna, D, Delmestri, A, Javaid, K, Cooper, C, Libanati, C, Toth, E, Abrahamsen, B, Prieto-Alhambra, D

Degenerative inter-vertebral disc disease (Osteochondrosis Intervertebralis) in Europe: prevalence, geographic variation, and radiological correlates in men and women aged 50 and over by Armbrecht, G, Felsenberg, D, Ganswindt, M, Lunt, M, Kaptoge, S, Abendroth, K, Aroso Dias, A, Bhalla, A, Cannata Andia, J, Dequeker, J, Eastell, R, Hoszowski, K, Lyritis, G, Masaryk, P, van Meurs, J, Miazgowski, T, Nuti, R, Poór, G, Redlund-Johnell, I, Reid, D, Schatz, H, Todd, C, Woolf, A, Rivadeneira, F, Javaid, M, Cooper, C, Silman, A, O'Neill, T, Reeve, J, European Vertebral Osteoporosis Study Group, European Prospective Osteoporosis Study Group

“…<strong>Objectives:</strong> To assess the prevalence across Europe of radiological indices of degenerative inter-vertebral disc disease (DDD); and to quantify their associations with, age, sex, physical anthropometry, areal bone mineral density (aBMD) and change in aBMD with time. …”

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom by Skjødt, MK, Khalid, S, Ernst, M, Rubin, KH, Martinez-Laguna, D, Delmestri, A, Javaid, MK, Cooper, C, Libanati, C, Toth, E, Abrahamsen, B, Prieto-Alhambra, D

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). by Bruyère, O, Cooper, C, Pelletier, J, Branco, J, Luisa Brandi, M, Guillemin, F, Hochberg, M, Kanis, J, Kvien, T, Martel-Pelletier, J, Rizzoli, R, Silverman, S, Reginster, J

“…The objective was to develop a treatment algorithm recommendation that is easier to interpret for the prescribing physician based on the available evidence and that is applicable in Europe and internationally. The knee was used as the model OA joint. …”

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). by Díez-Pérez, A, Hooven, F, Adachi, J, Adami, S, Anderson, F, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Delmas, P, Greenspan, S, Lacroix, A, Lindsay, R, Netelenbos, J, Pfeilschifter, J, Roux, C, Saag, K, Sambrook, P, Silverman, S, Siris, E, Watts, N, Nika, G, Gehlbach, S

“…Between 48% (U.S.A., Southern Europe) and 68% (Northern Europe) of women aged ≥65 years with a history of spine or hip fracture since age 45 were untreated. …”

Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: consensus of a working group of the ESCEO by Reginster, J, Arden, N, Haugen, I, Rannou, F, Cavalier, E, Bruyere, O, Branco, J, Chapurlat, R, Bassets, S, Al-Daghri, N, Dennisonm, E, Herrero-Beaumont, G, Laslop, A, Leeb, B, Maggi, S, Mkinsi, O, Povzun, A, Prieto-Alhambra, D, Thomas, T, Uebelhart, D, Veronese, N, Cooper, C

“…To gather expert opinion on the conduct of clinical trials that will facilitate regulatory review and approval of appropriate efficacious pharmacological treatments for hand osteoarthritis (OA), which there is currently no approved medication in Europe. …”

Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women. by Tom, SE, Adachi, J, Anderson, F, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Gehlbach, S, Greenspan, S, Hooven, F, Nieves, J, Pfeilschifter, J, Roux, C, Silverman, S, Wyman, A, LaCroix, A

“…OBJECTIVES: To test whether women aged 55 and older with increasing evidence of a frailty phenotype would have greater risk of fractures, disability, and recurrent falls than women who were not frail, across geographic areas (Australia, Europe, and North America) and age groups. DESIGN: Multinational, longitudinal, observational cohort study. …”

Frailty and fracture, disability, and falls: A multiple country study from the global longitudinal study of osteoporosis in women by Tom, SE, Adachi, J, Anderson, F, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Gehlbach, S, Greenspan, S, Hooven, F, Nieves, J, Pfeilschifter, J, Roux, C, Silverman, S, Wyman, A, Lacroix, A

“…Objectives To test whether women aged 55 and older with increasing evidence of a frailty phenotype would have greater risk of fractures, disability, and recurrent falls than women who were not frail, across geographic areas (Australia, Europe, and North America) and age groups. Design Multinational, longitudinal, observational cohort study. …”

Geographic variation in osteoporotic hip fracture incidence: the growing importance of asian influences in coming decades. by Dhanwal, D, Cooper, C, Dennison, E

“…There is also a north-south gradient, particularly in Europe, where more hip fractures occur in North Europe compared to the South.…”

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study. by O'Neill, T, Felsenberg, D, Varlow, J, Cooper, C, Kanis, J, Silman, A

“…Our aim was to determine the prevalence of radiographically defined vertebral deformity, as a marker of vertebral osteoporosis, in different regions and populations within Europe. We used a cross-sectional population-based survey. …”